Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2025 07:00 ET | Source: Micron Biomedical

Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants

Bill & Melinda Gates Foundation grants to accelerate manufacturing of Micron Biomedical’s needle-free technology for measles rubella vaccines